Peer2Peer: The Podcast

The best conversations about ophthalmology happen when leading surgeons sit down with their peers and explore topics big and small. Each episode brings together rotating hosts and their invited guests resulting in a mix of invaluable insights and unscripted moments you won’t want to miss. Published by Rayner.

Listen on:

  • Apple Podcasts
  • Podbean App
  • Spotify

Episodes

Thursday Apr 25, 2024

Dr Ben LaHood and Dr Rajen Desai discuss the complexities of selecting the right IOL for patients with glaucoma. They emphasise the need for a personalised approach to IOL selection while taking into consideration a multitude of factors, such a disease severity, patient lifestyles, and pupil size.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Thursday Mar 28, 2024

In January 2024, Rayner, a global leader in ophthalmic solutions, acquired THIS AG, the innovative Swiss manufacturer of the Sophi phacoemulsification machine. In this episode, Prof Paul Ursell, president of UKISCRS in the United Kingdom, engages in an exclusive interview with the CEO of Rayner, and the Vice President of R&D for Sophi and Managing Director of This AG, to explore the details of the acquisition and discuss the future of this collaboration.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner and Sophi are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Tuesday Feb 13, 2024

Hosted by Dr Ben LaHood, this special episode is in collaboration with Ophthalpreneurs and brings together the founder Amanda Cardwell Carones, alongside Mr Allon Barsam for an insightful discussion, sharing valuable insights on the crucial importance of enhancing patient counselling. Topics cover: mastering pre-surgery counselling, breaking communication barriers, and providing personalised care to achieve optimal outcomes in cataract and refractive surgery.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Tuesday Feb 06, 2024

In this episode of ‘Peer2Peer: The Podcast’, Dr. Eric Donnenfeld and Dr. John Hovanesian discuss a recent clinical study evaluating clinical efficacy and patient preference for a dropless treatment regimen following cataract surgery, as well as other innovative dropless solutions.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. OMIDRIA Podcasts are for the attention of USA HCPs only. OMIDRIA is distributed by Rayner Surgical Inc.
Rayner, the Rayner logo, OMIDRIA®, and the OMIDRIA logo are proprietary marks of Rayner. © 2024 Rayner Group, all rights reserved. US-OM-2300050 01/24
IMPORTANT SAFETY INFORMATION OMIDRIA® must be added to irrigating solution prior to use and is contraindicated in patients with known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported ocular adverse reactions at ≥2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.

Wednesday Jan 31, 2024

En este episodio especial de Peer2Peer: Podcast, grabado durante la 38º edición del Congreso SECOIR en España, el Dr. Mariano Royo, jefe del servicio de oftalmología del Hospital San Rafael y Ángel Jiménez, director de optometría, presentan el concepto de oftalmometría y discuten su importancia para la cirugía refractiva.
 
 
Este podcast se ofrece únicamente con fines de información general. Las opiniones de los presentadores son exclusivamente suyas. Nada de lo contenido en este podcast pretende ofrecer consejo médico para el tratamiento de ninguna enfermedad o dolencia, ni sustituir el consejo, diagnóstico o tratamiento médico profesional. Nada de lo presentado en este podcast tiene por objeto dar instrucciones u orientación sobre el uso de cualquier producto Rayner; no pretende reemplazar el juicio independiente de un cirujano sobre la idoneidad o los riesgos de un procedimiento para un paciente determinado. Rayner no respalda la utilización de productos para un uso distinto del indicado en sus instrucciones. Los usuarios deben consultar el etiquetado del producto y las instrucciones de uso de los productos Rayner en todos los casos. No todos los productos Rayner están disponibles en todos los países.
© 2024 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Wednesday Jan 31, 2024

En este episodio especial de Peer2Peer: Podcast, un panel de cirujanos del reconocido grupo oftalmológico Baviera se reúne en la 38º edición del Congreso SECOIR en España para compartir su experiencia en el día a día en consulta y quirófano y discutir sobre las últimas tendencias en oftalmología.
 
 
Este podcast se ofrece únicamente con fines de información general. Las opiniones de los presentadores son exclusivamente suyas. Nada de lo contenido en este podcast pretende ofrecer consejo médico para el tratamiento de ninguna enfermedad o dolencia, ni sustituir el consejo, diagnóstico o tratamiento médico profesional. Nada de lo presentado en este podcast tiene por objeto dar instrucciones u orientación sobre el uso de cualquier producto Rayner; no pretende reemplazar el juicio independiente de un cirujano sobre la idoneidad o los riesgos de un procedimiento para un paciente determinado. Rayner no respalda la utilización de productos para un uso distinto del indicado en sus instrucciones. Los usuarios deben consultar el etiquetado del producto y las instrucciones de uso de los productos Rayner en todos los casos. No todos los productos Rayner están disponibles en todos los países.
© 2024 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Tuesday Jan 23, 2024

Dr Ben LaHood and Dr Cyres Mehta analyse patient lifestyles, occupations and personality types to tailor their IOL selection.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2024 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Monday Dec 04, 2023

Dr. Paul Singh is joined by Dr. Arjan Hura and Dr. Karolinne Rocha at AECOS 2023 in Deer Valley to discuss why they are adopting OMIDRIA. They touch a multitude of topics including the importance of maintaining pupil stability, accessibility to the medication, patient selection, and patient experience.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. OMIDRIA Podcasts are for the attention of USA HCPs only. OMIDRIA is distributed by Rayner Surgical Inc.
Rayner, the Rayner logo, OMIDRIA, and the OMIDRIA logo are proprietary marks of Rayner. © 2023 Rayner Group, all rights reserved. US-OM-2300041 11/23
IMPORTANT SAFETY INFORMATION OMIDRIA® must be added to irrigating solution prior to use and is contraindicated in patients with known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. The most commonly reported ocular adverse reactions at ≥2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.

Tuesday Nov 14, 2023

Dr Neo Tapela and Dr Mor Dickman dive into the critical importance of patient reported outcomes and the technologies that foster them to the ophthalmic industry.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2023 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Tuesday Oct 31, 2023

Dr. Eric Rosenberg and Dr. Roger Zaldivar explore how surgeons can enhance their surgical techniques by integrating technology into their practices.
 
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2023 Rayner Group, all rights reserved. Rayner, RayPRO and RayOne are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539

Copyright 2023 All rights reserved.

Podcast Powered By Podbean

Version: 20240320